Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer.

Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive subtype of breast cancer with poor survival. Currently, the literature lacks comprehensive real-world evidence on locally recurrent and mTNBC patients. To validate the optimal treatment for patients with mTNBC, real-world...

Full description

Bibliographic Details

Published in:	Breast Cancer: Basic & Clinical Research pp. 1 - 10
Main Authors:	Celik, Alan, Berg, Tobias, Jensen, Maj-Britt, Jakobsen, Erik, Nielsen, Hanne Melgaard, Kümler, Iben, Glavicic, Vesna, Jensen, Jeanette Dupont, Knoop, Ann
Format:	research tables/charts Journal Article
Published:	Sage Publications Inc. 10/4/2023
Online Access:	View this record in EBSCOhost